Literature DB >> 32377551

Giving Credence to the Experience of X-Linked Hypophosphatemia in Adulthood: An Interprofessional Mixed-Methods Study.

Melissa Hughes1, Carolyn Macica1, Catherine Meriano2, Maya Doyle3.   

Abstract

PURPOSE: X-linked hypophosphatemia (XLH) is a rare X-linked dominant metabolic bone disease, often diagnosed in childhood but causing increasing physical debilitation and pain in adulthood. Physical comorbidities of XLH in adulthood include pervasive and early-onset degenerative arthritis, mineralizing enthesophytes and osteophytes, osteomalacia and pseudofracture, dental abscesses, and hearing loss.
METHODS: This mixed-methods analysis included physical findings, diagnostic imaging, occupational and physical therapy assessments, and semi-structured interviews by social work to understand the functional outcomes and lived experience of XLH in adulthood, through connections between qualitative data obtained by social work and occupational therapy with the quantitative findings from other disciplines.
RESULTS: Three primary themes of chronic pain, fear of falling, and lack of credence given by health care providers emerged from qualitative data and could be correlated with physical findings from functional outcome assessments These concerns contrasted with resilience, adaption, and compensation demonstrated by participants.
CONCLUSIONS: While new treatments may ease the burden of disease for adults with XLH, further research, increased provider awareness and education, and further development of standards of care are needed to promote accurate and adequate assessment and intervention for adults with XLH.
© 2020 Aurora Health Care, Inc.

Entities:  

Keywords:  X-linked hypophosphatemia; endocrine; musculoskeletal; occupational therapy; pain; physical therapy; providers; social work

Year:  2020        PMID: 32377551      PMCID: PMC7197891          DOI: 10.17294/2330-0698.1727

Source DB:  PubMed          Journal:  J Patient Cent Res Rev        ISSN: 2330-068X


  42 in total

1.  The Canadian occupational performance measure: an outcome measure for occupational therapy.

Authors:  M Law; S Baptiste; M McColl; A Opzoomer; H Polatajko; N Pollock
Journal:  Can J Occup Ther       Date:  1990-04       Impact factor: 1.614

2.  You Present like a Drug Addict: Patient and Clinician Perspectives on Trust and Trustworthiness in Chronic Pain Management.

Authors:  Daniel Z Buchman; Anita Ho; Judy Illes
Journal:  Pain Med       Date:  2016-01-11       Impact factor: 3.750

3.  X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children.

Authors:  M P Whyte; F W Schranck; R Armamento-Villareal
Journal:  J Clin Endocrinol Metab       Date:  1996-11       Impact factor: 5.958

4.  A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.

Authors:  Karl L Insogna; Karine Briot; Erik A Imel; Peter Kamenický; Mary D Ruppe; Anthony A Portale; Thomas Weber; Pisit Pitukcheewanont; Hae Il Cheong; Suzanne Jan de Beur; Yasuo Imanishi; Nobuaki Ito; Robin H Lachmann; Hiroyuki Tanaka; Farzana Perwad; Lin Zhang; Chao-Yin Chen; Christina Theodore-Oklota; Matt Mealiffe; Javier San Martin; Thomas O Carpenter
Journal:  J Bone Miner Res       Date:  2018-06-26       Impact factor: 6.741

5.  The Activities-specific Balance Confidence (ABC) Scale.

Authors:  L E Powell; A M Myers
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1995-01       Impact factor: 6.053

6.  Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms.

Authors:  Hélène Che; Christian Roux; Adrien Etcheto; Anya Rothenbuhler; Peter Kamenicky; Agnès Linglart; Karine Briot
Journal:  Eur J Endocrinol       Date:  2016-03       Impact factor: 6.664

7.  The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability.

Authors:  M Kosinski; S D Keller; H T Hatoum; S X Kong; J E Ware
Journal:  Med Care       Date:  1999-05       Impact factor: 2.983

8.  Measuring balance in the elderly: validation of an instrument.

Authors:  K O Berg; S L Wood-Dauphinee; J I Williams; B Maki
Journal:  Can J Public Health       Date:  1992 Jul-Aug

9.  Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS).

Authors:  Tanya Covic; Steven R Cumming; Julie F Pallant; Nick Manolios; Paul Emery; Philip G Conaghan; Alan Tennant
Journal:  BMC Psychiatry       Date:  2012-01-24       Impact factor: 3.630

10.  The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery.

Authors:  Christina Gummesson; Isam Atroshi; Charlotte Ekdahl
Journal:  BMC Musculoskelet Disord       Date:  2003-06-16       Impact factor: 2.362

View more
  8 in total

1.  An Evidence-based Physical Therapy Prescription for Adults With X-linked Hypophosphatemia.

Authors:  Karthik Kanamalla; Rebekah Fuchs; Casey Herzog; Keith D Steigbigel; Carolyn M Macica
Journal:  J Endocr Soc       Date:  2022-06-18

Review 2.  Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.

Authors:  Michaël R Laurent; Jean De Schepper; Dominique Trouet; Nathalie Godefroid; Emese Boros; Claudine Heinrichs; Bert Bravenboer; Brigitte Velkeniers; Johan Lammens; Pol Harvengt; Etienne Cavalier; Jean-François Kaux; Jacques Lombet; Kathleen De Waele; Charlotte Verroken; Koenraad van Hoeck; Geert R Mortier; Elena Levtchenko; Johan Vande Walle
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-19       Impact factor: 5.555

3.  Lower Limb Deformity and Gait Deviations Among Adolescents and Adults With X-Linked Hypophosphatemia.

Authors:  Gabriel T Mindler; Andreas Kranzl; Alexandra Stauffer; Roland Kocijan; Rudolf Ganger; Christof Radler; Gabriele Haeusler; Adalbert Raimann
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-27       Impact factor: 5.555

4.  Health Care Transition From Pediatric- to Adult-Focused Care in X-linked Hypophosphatemia: Expert Consensus.

Authors:  Kathryn Dahir; Ruban Dhaliwal; Jill Simmons; Erik A Imel; Gary S Gottesman; John D Mahan; Gnanagurudasan Prakasam; Allison I Hoch; Prameela Ramesan; Maria Díaz-González de Ferris
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

5.  Concordance between the schedule for the evaluation of individual quality of life-direct weighting (SEIQoL-DW) and the EuroQoL-5D (EQ-5D) measures of quality of life outcomes in adults with X-linked hypophosphatemia.

Authors:  Ravi Jandhyala
Journal:  Orphanet J Rare Dis       Date:  2022-02-23       Impact factor: 4.123

6.  Patient-Reported Complications, Symptoms, and Experiences of Living With X-Linked Hypophosphatemia Across the Life-Course.

Authors:  Moira Cheung; Angela J Rylands; Angela Williams; Karen Bailey; Judith Bubbear
Journal:  J Endocr Soc       Date:  2021-04-23

7.  Oral health-related quality of life in patients with X-linked hypophosphatemia: a qualitative exploration.

Authors:  Caroline Nguyen; Elisabeth Celestin; Delphine Chambolle; Agnès Linglart; Martin Biosse Duplan; Catherine Chaussain; Lisa Friedlander
Journal:  Endocr Connect       Date:  2022-01-28       Impact factor: 3.335

8.  An Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia.

Authors:  Fahad Aljuraibah; Justine Bacchetta; Maria Luisa Brandi; Pablo Florenzano; Muhammad K Javaid; Outimaija Mäkitie; Adalbert Raimann; Mariano Rodriguez; Heide Siggelkow; Dov Tiosano; Marc Vervloet; Carsten A Wagner
Journal:  J Bone Miner Res       Date:  2021-12-23       Impact factor: 6.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.